The strong of OTC drugs, Dongwha Pharm, expanded to CNS infections
The oldest company, Dongwha Pharm, has domestically acquired an approval for the new quinolones-type antibiotic for the third time after Factive and Q-Roxin.
On the last 20th, Dongwha has acquired a product approval for the self-developed quinolones-type antibiotic ‘Zabolante’. The indicant of t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
